These results demonstrate that the expression of GPA33 shows strong intratumoral heterogeneity in CRC and is lost in undifferentiated subsets of tumor cells with high oncogenic signaling activity that may be primed to undergo EMT at the infiltrative tumor edge. The gene discussed is GPA33; the disease is neoplasm.